Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA.
about
Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis.Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population.Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection.
P2860
Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cost-effectiveness of colorect ...... lasma methylated Septin 9 DNA.
@ast
Cost-effectiveness of colorect ...... lasma methylated Septin 9 DNA.
@en
type
label
Cost-effectiveness of colorect ...... lasma methylated Septin 9 DNA.
@ast
Cost-effectiveness of colorect ...... lasma methylated Septin 9 DNA.
@en
prefLabel
Cost-effectiveness of colorect ...... lasma methylated Septin 9 DNA.
@ast
Cost-effectiveness of colorect ...... lasma methylated Septin 9 DNA.
@en
P2093
P2860
P921
P356
P1476
Cost-effectiveness of colorect ...... lasma methylated Septin 9 DNA.
@en
P2093
Bernd Brueggenjuergen
Lourdes Alvarez-Osorio
Thomas Rösch
Uri Ladabaum
P2860
P304
P356
10.1055/S-0034-1377182
P577
2014-06-06T00:00:00Z